(Q30430971)

1 September 2017

Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma (English)

1 reference

head and neck squamous cell carcinoma

1 September 2017

1 reference

6

1 reference

1 September 2017

Hanbyoul Cho

4

0 references

Joon-Yong Chung

object named as

Joon-Yong Chung

3

0 references

Christopher Moskaluk

7

object named as

Christopher A Moskaluk

1 reference

1 September 2017

Mikiko Takikita

1

1 reference

1 September 2017

Ran Xie

2

1 reference

1 September 2017

Kris Ylaya

5

1 reference

1 September 2017

29 July 2011

1 reference

Journal of Translational Medicine

1 September 2017

1 reference

1 September 2017

9

1 reference

1 September 2017

126

1 reference

https://scigraph.springernature.com/pub.10.1186/1479-5876-9-126

1 September 2017

0 references

cites work

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

EGFR antagonists in cancer treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

The effects of antibody clone and pretreatment method on the results of HER2 immunostaining in cytologic samples of metastatic breast cancer: A query and a review of the literature

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

ERBB receptors and cancer: the complexity of targeted inhibitors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Developing inhibitors of the epidermal growth factor receptor for cancer treatment.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Smart drugs: tyrosine kinase inhibitors in cancer therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

The ErbB signaling network: receptor heterodimerization in development and cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Tissue microarrays for high-throughput molecular profiling of tumor specimens

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

C-erbB-2 expression in squamous cell carcinoma of the head and neck

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Expression of c-erbB-2 gene in human head and neck carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162511

Common and distinct elements in cellular signaling via EGF and FGF receptors

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

High expression of HER3 is associated with a decreased survival in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

ErbB-3 predicts survival in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-126

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

21 January 2018

1 reference

12 December 2020

Expression of erbB-3 protein in colorectal adenocarcinoma: correlation with poor survival

1 reference

12 December 2020

c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival

1 reference

12 December 2020

Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

1 reference

12 December 2020

Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay

1 reference

12 December 2020

Immunohistochemical localization of c-erbB-2 in human breast carcinomas

1 reference

12 December 2020

Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon

1 reference

12 December 2020

Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival

1 reference

12 December 2020

Monoclonal antibody therapy of cancer

1 reference

12 December 2020

EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases

1 reference

12 December 2020

Identifiers

DOI

10.1186/1479-5876-9-126

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference

1 September 2017

PubMed publication ID

21801427

1 reference